Pembrolizumab for the treatment of uveal melanoma: A case series

Uveal melanoma is a rare disease. Up to 50% of the patients will develop metastases for which the treatment options are limited. No randomized controlled data for the treatment of uveal melanoma patients are available. In this study we describe the clinical course of nine uveal melanoma patients inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Jansen, Yanina Jeanne Leona, Seremet, Teofila, Neyns, Bart
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7675863/
https://www.ncbi.nlm.nih.gov/pubmed/33240475
http://dx.doi.org/10.1177/2036361320971983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7675863/
https://www.ncbi.nlm.nih.gov/pubmed/33240475
http://dx.doi.org/10.1177/2036361320971983

Ejemplares similares